Structure | Chemical Name | CAS | MF |
|
EPITHELIALBASEMENTMEMBRANEANTIGEN(EMA),CLONE:MFGM/5/11(ICR.2),RATMABANTI-:PARAFFIN,IH
|
|
|
|
EPITHELIALMEMBRANEANTIGEN(EMA),MABANTI-HUMAN,FROZEN/PARAFFIN(W/NBREAG.)
|
|
|
|
EPITHELIALANTIGEN,CLONE:BER-EP4,MABANTI-HUMAN
|
|
|
|
epitheliasin
|
|
|
|
11-EPI TH 'F'
|
|
C21H34O5
|
|
epithelial V-like antigen
|
|
|
|
epithane-3
|
77190-13-7
|
|
|
EPITHELIALSPECIFICANTIGEN(ESA),40KD,CLONE:VU-1D9,MABANTI-
|
|
|
|
epithelial membrane protein 3
|
|
|
|
1-(2',3'-epithio-2',3'-dideoxy-beta-D-lyxofuranosyl)thymine 5'-triphosphate
|
152158-09-3
|
C10H15N2O13P3S
|
|
EPITHELIALMEMBRANEANTIGEN,35KD,CLONE:HEA125,MABANTI-HUMAN:FROZEN/PARAFFIN,IH
|
|
|
|
EpithelialSpecificAntigen(Hea)
|
|
|
|
EpithelialMucinAntigen(Mc5)
|
|
|
|
EPITHELIALMEMBRANEANTIGEN(EMA),CLONE:E29,MABANTI-HUMAN,FITC
|
|
|
|
epithienamycin E
|
79057-46-8
|
C13H16N2O8S2
|
|
epithelial membrane glycoprotein PAS-IV
|
|
|
|
EPITHELIALSPECIFICANTIGEN(ESA),40KD,CLONE:B29.1(VU-ID9),MABANTI-HUMAN:FROZEN/PARAFFIN
|
|
|
|
1,4-Epithiopyrido[1,2-a]benzimidazole(9CI)
|
77925-15-6
|
C11H6N2S
|
|
4,9-Epithio-1H-naphth[2,3-d]imidazole(9CI)
|
337973-25-8
|
C11H6N2S
|
|
EPITHELIALMEMBRANEANTIGEN,MABANTI-
|
|
|
|
4,5-Epithioheptadecanoic acid methyl ester
|
|
C18H34O2S
|
|
7,8-Epithiostearic acid methyl ester
|
|
C19H36O2S
|
|
4,5-Epithiohenicosanoic acid methyl ester
|
|
C22H42O2S
|
|
15,16-Epithiodocosanoic acid methyl ester
|
|
C23H44O2S
|
|
8,9-Epithiodocosanoic acid methyl ester
|
|
C23H44O2S
|
|
8,9-Epithiononadecanoic acid methyl ester
|
|
C20H38O2S
|
|
3,4-Epithioicosanoic acid methyl ester
|
|
C21H40O2S
|
|
9β,10β-Epithio-1α,4α-dimethoxy-1,4,4aβ,9,9aβ,10-hexahydroanthracene 11-oxide
|
|
|
|
11,12-Epithiononadecanoic acid methyl ester
|
|
C20H38O2S
|
|
9,10-Epithiodocosanoic acid methyl ester
|
|
C23H44O2S
|
|
13,14-Epithiodocosanoic acid methyl ester
|
|
C23H44O2S
|
|
19,20-Epithiohenicosanoic acid methyl ester
|
|
C22H42O2S
|
|
9,10-Epithiotricosanoic acid methyl ester
|
|
C24H46O2S
|
|
15,16-Epithiohexadecanoic acid methyl ester
|
|
C17H32O2S
|
|
13,14-Epithioheptadecanoic acid methyl ester
|
|
C18H34O2S
|
|
20,21-Epithiotricosanoic acid methyl ester
|
|
C24H46O2S
|
|
14,15-Epithiopentadecanoic acid methyl ester
|
|
C16H30O2S
|
|
16,17-Epithioicosanoic acid methyl ester
|
|
C21H40O2S
|
|
2,3-Epithiotricosanoic acid methyl ester
|
|
C24H46O2S
|
|
20,21-Epithiodocosanoic acid methyl ester
|
|
C23H44O2S
|
|
5,6-Epithioheptadecanoic acid methyl ester
|
|
C18H34O2S
|
|
9β,10β-Epithio-1α,4α-dihydroxy-1,4,4aβ,9,9aβ,10-hexahydroanthracene 11-oxide
|
|
|
|
17,18-Epithiodocosanoic acid methyl ester
|
|
C23H44O2S
|
|
3,4-Epithiopalmitic acid methyl ester
|
|
C17H32O2S
|
|
10,11-Epithioheptadecanoic acid methyl ester
|
|
C18H34O2S
|
|
4,5-Epithiooctadecanoic acid methyl ester
|
|
C19H36O2S
|
|
2,3-Epithioicosanoic acid methyl ester
|
|
C21H40O2S
|
|
9,10-Epithiononadecanoic acid methyl ester
|
|
C20H38O2S
|
|
14,15-Epithiooctadecanoic acid methyl ester
|
|
C19H36O2S
|
|
2,3-Epithiostearic acid methyl ester
|
|
C19H36O2S
|
|
9β,10β-Epithio-1β,4β-diacetoxy-1,4,4aα,9,9aα,10-hexahydroanthracene 11-oxide
|
|
|
|
2,3-Epithiopentadecanoic acid methyl ester
|
|
C16H30O2S
|
|
Epitheaflavic acid
|
30407-94-4
|
C21H16O10
|
|
6,7-Epithiopentadecanoic acid methyl ester
|
|
C16H30O2S
|
|
7,8-Epithiohenicosanoic acid methyl ester
|
|
C22H42O2S
|
|
6,7-Epithiononadecanoic acid methyl ester
|
|
C20H38O2S
|
|
19,20-Epithiodocosanoic acid methyl ester
|
|
C23H44O2S
|
|
16,17-Epithiotricosanoic acid methyl ester
|
|
C24H46O2S
|
|
16,17-Epithiostearic acid methyl ester
|
|
C19H36O2S
|
|
6,7-Epithioicosanoic acid methyl ester
|
|
C21H40O2S
|
|
15,16-Epithioicosanoic acid methyl ester
|
|
C21H40O2S
|
|
7,8-Epithiotricosanoic acid methyl ester
|
|
C24H46O2S
|
|
17,18-Epithiotricosanoic acid methyl ester
|
|
C24H46O2S
|
|
5,6-Epithiopalmitic acid methyl ester
|
|
C17H32O2S
|
|
14,15-Epithiopalmitic acid methyl ester
|
|
C17H32O2S
|
|
18,19-Epithiodocosanoic acid methyl ester
|
|
C23H44O2S
|
|
3,4-Epithiopentadecanoic acid methyl ester
|
|
C16H30O2S
|
|
16,17-Epithioheptadecanoic acid methyl ester
|
|
C18H34O2S
|
|
5,8-Epithioindolizine(9CI)
|
330658-04-3
|
C8H5NS
|
|
EPITHELIALSPECIFICANTIGEN(ESA),40KD,CLONE:B29.1(VU-ID9),MABANTI-HUMAN,BIOTIN
|
|
|
|
10,11-Epithiononadecanoic acid methyl ester
|
|
C20H38O2S
|
|
9,10-Epithioicosanoic acid methyl ester
|
|
C21H40O2S
|
|
EpithelialMembraneAntigen(Ema)265-400Kda
|
|
|
|
EPITHIOCHLORHYDRIN
|
3221-15-6
|
C3H5ClS
|
|
2,8-EPITHIO-P-MENTHANE
|
68398-18-5
|
C10H18S
|
|
EPITHALON, [ALANINE-14C(U)]-
|
|
|
|
EPITHELIAL CELL EXTRACT
|
|
|
|
EPITHALON, [ALANINE-14C(U)]- 50-120 MCI(1.85-4.44 GBQ)/MMOL, MORPURE HPLC PURIFIED, DELIVERED >= 98% PURE WITH HPLC RADIOCHROMATOGRAM
|
|
|
|
11-EPI TH 'B'
|
|
C21H34O4
|
|
1,4-Epithio-1H,3H-(1,4)oxazepino(4,3-a)benzimidazole, 4,5-dihydro-1-ph enyl-
|
76099-31-5
|
C17H14N2OS
|
|
EPITHELIALRELATEDANTIGEN,MOC-31L,MABANTI-HUMAN
|
|
|
|
EPITHELIALSIALOMUCIN(ESM),CLONE:140C1,MABANTI-
|
|
|
|
EPITHELIALSPECIFICANTIGEN(ESA),EP-CAM,CLONE:VU-1D9,MABANTI-HUMAN:FROZEN/PARAFFIN,IH
|
|
|
|
epithelin 2
|
|
|
|
Epithelial Transport: AGuide to Methods and Experimental Analysis
|
|
|
|
epithelial calcium channel 2, human
|
|
|
|
epithelin 1
|
|
|
|
5,6-Epithiotricosanoic acid methyl ester
|
|
C24H46O2S
|
|
7,8-Epithioicosanoic acid methyl ester
|
|
C21H40O2S
|
|
5,6-Epithioicosanoic acid methyl ester
|
|
C21H40O2S
|
|
13,14-Epithiohexadecanoic acid methyl ester
|
|
C17H32O2S
|
|
14,15-Epithiohenicosanoic acid methyl ester
|
|
C22H42O2S
|
|
15,16-Epithiohenicosanoic acid methyl ester
|
|
C22H42O2S
|
|
7,8-Epithiodocosanoic acid methyl ester
|
|
C23H44O2S
|
|
13,14-Epithiopentadecanoic acid methyl ester
|
|
C16H30O2S
|
|
14,15-Epithiononadecanoic acid methyl ester
|
|
C20H38O2S
|
|
8,9-Epithioheptadecanoic acid methyl ester
|
|
C18H34O2S
|
|
6,7-Epithiohenicosanoic acid methyl ester
|
|
C22H42O2S
|
|
Epitheaflavic acid-3'-gallate
|
|
|
|
13,14-Epithiononadecanoic acid methyl ester
|
|
C20H38O2S
|